NeuroOne to Announce Q3 FY2025 Results with Key Updates

NeuroOne to Share Third Quarter Fiscal Year 2025 Results

EDEN PRAIRIE, Minn. – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a pioneering medical technology firm, is on the verge of unveiling its financial outcomes from the third quarter that ended on June 30, 2025. The announcement is slated for August 14, 2025, prior to the market opening, marking a significant moment for the company and its stakeholders.

On this day, the management team will conduct an investor conference call and webcast, beginning at 8:30 a.m. Eastern Time. The call will provide insights into the company’s latest financial results for the third quarter as well as updates on corporate developments, wrapped up with a Q&A session for participants. This engagement gives investors a chance to deepen their understanding of the company's status and future strategies.

Details of the Earnings Conference Call

Here is the vital information for those wishing to participate in the third quarter earnings conference call:

Earnings Conference Call
Date: August 14, 2025
Time: 8:30 a.m. Eastern Time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 939482

For those interested, a webcast link will be provided, allowing for streaming of the conference. It's recommended to join the call at least five minutes early to ensure participation.

Replay of the Conference Call

A playback of the earnings call will be accessible through August 28, 2025. Listeners can call 877-481-4010 in the United States or 919-882-2331 for international access, using the replay passcode 52598. For those who prefer an online format, a webcast replay will also be made available through the provided link.

Overview of NeuroOne's Innovation

NeuroOne Medical Technologies Corporation is dedicated to pioneering minimally invasive and high-definition technology solutions focused primarily on addressing neurological conditions. The innovations developed by NeuroOne aim to enhance EEG recordings, brain stimulation, and ablation procedures, catering to patients grappling with epilepsy, Parkinson’s disease, and other neurological ailments that can significantly affect their quality of life.

This company, recognized for its commitment to improving surgical care options, is revolving its solutions not only around neurological disorders but is also exploring applications that may aid in combating depression, mood disorders, chronic pain, incontinence, and even integrating artificial intelligence into its technology. The evolving landscape of healthcare presents a robust opportunity for NeuroOne to potentially decrease procedural costs while elevating patient outcomes.

Advancements and Future Prospects

The initiatives underway at NeuroOne reflect a forward-thinking approach within the medical technology sector. By capable innovation, the company aspires to create a ripple effect that enriches patient care and surgical precision. As advancements in medical technology continue to grow, NeuroOne stands at the forefront, ready to leverage new possibilities in the treatment landscape.

Investors are looking forward to the financial outcomes of the third quarter as a significant indicator of the company’s future trajectory. This release holds the promise of showcasing how effectively NeuroOne is progressing within an intensely competitive field dedicated to enhancing life for those affected by debilitating conditions.

Frequently Asked Questions

What is the date for NeuroOne’s third quarter earnings report?

NeuroOne will report its third quarter fiscal year 2025 earnings on August 14, 2025.

What time will the earnings conference call be held?

The earnings conference call is scheduled for 8:30 a.m. Eastern Time on August 14, 2025.

How can I participate in the conference call?

You can participate by dialing the provided U.S. or international numbers along with the participant access code.

Will a replay of the earnings call be available?

Yes, a replay will be available until August 28, 2025, and can be accessed by calling the provided numbers.

What areas of medical treatment is NeuroOne focusing on?

NeuroOne is focused on improving solutions for neurological conditions and is exploring applications in various disorders, including depression and chronic pain.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.